Application 018461
- Type
- NDA
- Sponsor
- BAXTER HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 100MG/100ML | No | No |
| 002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 200MG/100ML | No | No |
| 003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 400MG/100ML | No | No |
| 004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 800MG/100ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | ||
| N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | |
| N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | |
| N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | LIDOCAINE HYDROCHLORIDE | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N018461-002 | AP |
| N018461-003 | AP |
| N018461-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N018461-001 | LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER | 100MG/100ML | INJECTABLE / INJECTION | Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N018461-002 | LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N018461-003 | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/100ML | INJECTABLE / INJECTION | AP | Approved before 1982 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N018461-004 | LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER | 800MG/100ML | INJECTABLE / INJECTION | AP | 1982-02-22 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N018461-002 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N018461-003 | AP | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N018461-004 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N018461-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N018461-003 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N018461-004 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N018461-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N018461-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N018461-004 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N018461-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018461-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N018461-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018461-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018461-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018461-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N018461-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018461-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N018461-004 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018461-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018461-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018461-004 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018461-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018461-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018461-004 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018461-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018461-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018461-004 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018461-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018461-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018461-004 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018461-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018461-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018461-004 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018461-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018461-003 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018461-004 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N018461-002 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018461-003 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N018461-004 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018461-002 | AP | 1 | 79d66fd596c7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE | Baxter Healthcare Corporation | f21512ea-c7c3-4766-b976-b2c0b5616bf0 | 2026-02-20 | Warnings, Adverse reactions | 018461 NDA018461 0338-0409 0338-0411 |
| LIDOCAINE HYDROCHLORIDE AND DEXTROSE | LIDOCAINE HYDROCHLORIDE AND DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 1bf999b5-e290-dcbd-e063-6294a90a2bab | 2026-01-20 | Warnings, Adverse reactions | 018461 NDA018461 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0338-0409 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0409 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0409 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0409 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0409 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0411 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0411 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0411 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0411 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 0338-0411 | Lidocaine Hydrochloride and Dextrose | Lidocaine Hydrochloride | Baxter Healthcare Corporation | NDA | Current |
| 51662-1302 | LIDOCAINE HCI AND DEXTROSE | LIDOCAINE HCI AND DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1302 | LIDOCAINE HCI AND DEXTROSE | LIDOCAINE HCI AND DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1302 | LIDOCAINE HCI AND DEXTROSE | LIDOCAINE HCI AND DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |